Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline

Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline

US Patent 7582762 · Granted Sep 1, 2009

Estimated economic value: $44,457,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1-en-1-yl]-2-methylbenzyl}-5-(pr2017
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 12012
Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperi2012
Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperi2012
Olanzapine pamoate dihydrate2011
Crystalline variable hydrate of (S)-6-(4-(2-((3-9H-carbazol-4-yloxy)-2-hydroxypr2010
Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[12008
Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosub2007
Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosub2007
Hemihydrate of a selective functional M1 muscarine receptor agonist2007
Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL2006
Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-metho2003